INDIVIDUAL TEST 132
Certolizumab
Indication
Monitoring of Certolizumab level
Sample material
Serum
- Minim. volume: 0,5 mL
Transport
- Within Sweden: room temperature
- International: room temperature
Method
- ELISA
Result
Drug concentration is reported as µg/mL.
Interpretation
Certolizumab acts as a TNF-alpha inhibitor. The sample should be drawn at trough value. Low or unmeasurable concentration of the biologic pharmaceutical is associated with poor clinical effect and increase in dosing should be considered. Antibodies against Certolizumab (anti-drug antibodies, ADA) are rare.
Last updated: 2025-06-02
Can't find what you're looking for? We are here to help
ENSKILD ANALYS 132
Certolizumab
Indikation
Monitorering av Certolizumab-koncentration
Provmaterial
Serum
- Minim. volym: 0,5 mL
Transport
- Inom Sverige: rumstemperatur
- Internationellt: rumstemperatur
Metod
- ELISA
Resultat
Läkemedelskoncentrationen anges i µg/mL.
Tolkning
Certolizumab verkar som TNF-alfa-hämmare. Provet bör tas vid dalvärde. Låg eller omätbar koncentration av biologiskt läkemedel är associerat med sämre klinisk effekt och dosökning kan övervägas. Antikroppar mot Certolizumab (anti-läkemedelsantikroppar, ADA) utvecklas sällan.
Senast uppdaterat: 2025-06-02